A phase III trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy in patients with high risk, early stage endometrial carcinoma
Principal Investigator
Marcus Randall, MD
Status
Terminated
Date of Study Termination
July 17 2020
Disease Site
Gynecologic [GY]
Uterine Corpus
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine if treatment with vaginal cuff brachytherapy followed by three cycles of chemotherapy reduces the rate of recurrence or death (i.e. increases recurrence-free survival) when compared to pelvic radiation therapy.
Patient Population
Patients with high risk, early stage endometrial cancer.
Target Accrual
562
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.